IL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice

Journal of Immunology

Volumn 180, Issue 6, 2008, Pages 4090-4097

  Anderson, Charles F ^a   Lira, Rosalia ^a,b   Kamhawi, Shaden ^a   Belkaid, Yasmine ^a   Wynn, Thomas A ^a   Sacks, David ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LEISHMANIA TROPICA; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PHLEBOTOMUS; PRIORITY JOURNAL; PROMASTIGOTE; SIGNAL TRANSDUCTION; SKIN LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHRONIC DISEASE; DISEASE CARRIER; DISEASE MODEL; DISEASE TRANSMISSION; EXTERNAL EAR; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; MOUSE MUTANT; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EAR, EXTERNAL; HOST-PARASITE INTERACTIONS; IMMUNITY, NATURAL; INSECT VECTORS; INTERLEUKIN-10; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PHLEBOTOMUS; TRANSFORMING GROWTH FACTOR BETA;

EID: 44849131503     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.6.4090     Document Type: Article

References (26)

1. Reithinger, R., M. Mohsen, K. Aadil, M. Sidiqi, P. Erasmus, and P. G. Coleman. 2003. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg. Infect. Dis. 9: 727-729.
2. Brooker, S., N. Mohammed, K. Adil, S. Agha, R. Reithinger, M. Rowland, I. Ali, and J. Kolaczinski. 2004. Leishmaniasis in refugee and local Pakistani populations. Emerg. Infect. Dis. 10: 1681-1684.
3. Kolaczinski, J., S. Brooker, H. Reyburn, and M. Rowland. 2004. Epidemiology of anthroponotic cutaneous leishmaniasis in Afghan refugee camps in northwest Pakistan. Trans. R. Soc. Trop. Med. Hyg. 98: 373-378.
4. Momeni, A. Z., and M. Aminjavaheri. 1994. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int. J. Dermatol. 33: 260-265.
5. Magill, A. J., M. Grogl, R. A. Gasser, Jr., W. Sun, and C. N. Oster. 1993. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N. Engl. J. Med. 328: 1383-1387.
6. Dillon, D. C., C. H. Day, J. A. Whittle, A. J. Magill, and S. G. Reed. 1995. Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients. Proc. Natl. Acad. Sci. USA 92: 7981-7985.
7. Bastien, P., and R. Killick-Kendrick. 1992. Leishmania tropica infection in hamsters and a review of the animal pathogenicity of this species. Exp. Parasitol. 75: 433-441.
8. Lira, R., S. Mendez, L. Carrera, C. Jaffe, F. Neva, and D. Sacks. 1998. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp. Parasitol. 89: 331-342.
9. Schnur, L. F., A. Nasereddin, C. L. Eisenberger, C. L. Jaffe, M. El Fari, K. Azmi, G. Anders, M. Killick-Kendrick, R. Killick-Kendrick, J. P. Dedet, et al. 2004. Multifarious characterization of Leishmania tropica from a Judean desert focus, exposing intraspecific diversity and incriminating phlebotomus sergenti as its vector. Am. J. Trop. Med. Hyg. 70: 364-372.
10. Spath, G. F., and S. M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103.
11. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165: 969-977.
12. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
13. Mendez, S., S. Gurunathan, S. Kamhawi, Y. Belkaid, M. A. Moga, Y. A. Skeiky, A. Campos-Neto, S. Reed, R. A. Seder, and D. Sacks. 2001. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J. Immunol. 166: 5122-5128.
14. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-1506.
15. Reed, S. G. 1999. TGF-β in infections and infectious diseases. Microbes Infect. 1: 1313-1325.
16. Murray, H. W., C. M. Lu, S. Mauze, S. Freeman, A. L. Moreira, G. Kaplan, and R. L. Coffman. 2002. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70: 6284-6293.
17. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297.
18. Wilson, M. E., B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan. 1998. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161: 6148-6155.
19. Wilson, M. E., T. J. Recker, N. E. Rodriguez, B. M. Young, K. K. Burnell, J. A. Streit, and J. N. Kline. 2002. The TGF-β response to Leishmania chagasi in the absence of IL-12. Eur. J. Immunol. 32: 3556-3565.
20. Murray, H. W., K. C. Flanders, D. D. Donaldson, J. P. Sypek, P. J. Gotwals, J. Liu, and X. Ma. 2005. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect. Immun. 73: 3903-3911.
21. Barral, A., M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90: 3442-3446.
22. Padigel, U. M., and J. P. Farrell. 2005. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common γ-chain for FcR is associated with reduced production of IL-10 and TGF-β by parasitized cells. J. Immunol. 174: 6340-6345.
23. Li, J., C. A. Hunter, and J. P. Farrell. 1999. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162: 974-979.
24. McDowell, M. A., M. Marovich, R. Lira, M. Braun, and D. Sacks. 2002. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70: 3994-4001.
25. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146: 2763-2770.
26. Guevara-Mendoza, O., C. Une, P. Franceschi Carreira, and A. Orn. 1997. Experimental infection of BALB/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-γ but not IL-4 is associated with the development of cutaneous lesions. Scand. J. Immunol. 46: 35-40.